Galderma Rosacea
Laufzeit: 01.01.2012 - 31.12.2014
Kurzfassung
Efficacy and safety of CD5024 1% cream versus metronidazole 0.75% cream in subjects with papulopustular rosacea over 16 weeks treatment, followed by a 36-week extension period.
Laufzeit: 01.01.2012 - 31.12.2014
Efficacy and safety of CD5024 1% cream versus metronidazole 0.75% cream in subjects with papulopustular rosacea over 16 weeks treatment, followed by a 36-week extension period.
